Great Lakes Advisors’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.4K Buy
+12,735
New +$76.9K ﹤0.01% 818
2025
Q1
Sell
-179,345
Closed -$6.17M 857
2024
Q4
$6.17M Sell
179,345
-5,801
-3% -$262K 0.05% 269
2024
Q3
$9.15M Sell
185,146
-9,068
-5% -$465K 0.08% 213
2024
Q2
$11.7M Sell
194,214
-10,936
-5% -$625K 0.1% 184
2024
Q1
$10.6M Buy
205,150
+1,135
+0.6% +$55.7K 0.09% 202
2023
Q4
$8.23M Buy
+204,015
New +$5.98M 0.08% 226

Other funds holding RXST

Great Lakes Advisors's RXST Position: Q2 2026 in Review

Great Lakes Advisors opened a new position in RxSight (RXST) in Q2 2026: 12,735 shares worth $61.4K. The stake represents ﹤0.01% of the portfolio and ranks #818 among its holdings. This is a return to the name: Great Lakes Advisors previously reported a position in RXST as recently as Q4 2024.

Great Lakes Advisors first reported a position in RXST in Q4 2023 and has held it in 6 quarters since. The position peaked at $11.7M in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Great Lakes Advisors held 12,735 shares of RxSight worth $61.4K as of Q2 2026.
  • RxSight was a new Great Lakes Advisors position in Q2 2026.
  • RxSight made up ﹤0.01% of Great Lakes Advisors's portfolio in Q2 2026, its #818 holding.
  • Great Lakes Advisors first reported a position in RxSight in Q4 2023 and has held it in 6 quarters since.
  • Great Lakes Advisors's RxSight position peaked at $11.7M in Q2 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.